A modified HLA-A*0201-restricted CTL epitope from human oncoprotein (hPEBP4) induces more efficient antitumor responses

We previously identified human phosphatidylethanolamine-binding protein 4 (hPEBP4) as an antiapoptotic protein with increased expression levels in breast, ovarian and prostate cancer cells, but low expression levels in normal tissues, which makes hPEBP4 an attractive target for immunotherapy. Here,...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Cell Mol Immunol
Glavni autori: Sun, Weihong, Shi, Junyi, Wu, Jian, Zhang, Junchu, Chen, Huabiao, Li, Yuanyuan, Liu, Shuxun, Wu, Yanfeng, Tian, Zhigang, Cao, Xuetao, Li, Nan
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6141579/
https://ncbi.nlm.nih.gov/pubmed/29375131
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cmi.2017.155
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items